<DOC>
	<DOCNO>NCT00847158</DOCNO>
	<brief_summary>This prospective , double-masked , 15-month clinical trial compare efficacy phacoemulsification alone combine phacoemulsification implantation iStentÂ® trabecular micro-bypass stent patient primary open-angle glaucoma .</brief_summary>
	<brief_title>A Clinical Trial Phacoemulsification Versus Phacoemulsification &amp; iStent Implantation POAG Patients</brief_title>
	<detailed_description>This prospective , randomize open-label study 36 patient POAG schedule undergo phacoemulsification intraocular lens implantation ( `` cataract surgery '' ) . Patients randomize 2:1 receive either cataract surgery alone ( control group ) cataract surgery iStent implantation ( combine surgery group ) . Implantation study stent occur cataract extraction IOL insertion use small , temporal , clear-corneal incision ( approximately 3 mm ) use perform phacoemulsification IOL placement . The study stent guide Schlemm 's canal use ab-interno gonioscopy ( use Swan-Jacobs gonioscope ) . ( Figure 1 ) If complication occur phacoemulsification , acetylcholine inject anterior chamber IOL implantation constrict pupil . The anterior chamber fill viscoelastic agent reform anterior chamber provide clearance angle . The anterior chamber traverse applicator ( implant tip applicator ) trabecular meshwork locate . The lead edge device gently slide trabecular meshwork Schlemm 's canal nasal position ( 3 4 o'clock right eye ; 9 8 o'clock leave eye ) tip implant direct inferiorly . If difficulty encounter insertion primary location , try insert 0.5 clock hour inferiorly ; continue move inferiorly need subsequent attempt . Next , device release push button applicator , position stent verify applicator withdrawn . The patient instruct discontinue glaucoma medication surgery . Standard post cataract extraction antibiotic anti-inflammatory drug regimen prescribe . Target pressure patient determine prior study entry . Following assigned procedure , patient IOP ( measure 8 10 AM ) great 2 mm Hg target instruct return twice follow three day re-measurement IOP . If patient 's IOP &gt; 2 mm Hg target pressure , ocular hypotensive agent add . The medication add pre-set schedule , beta-blockers first , angiotensin-converting enzyme ( ACE ) inhibitor second , prostaglandins third . If , however , third consecutive visit patient 's IOP within 2 mm Hg target , patient re-entered normal visit schedule . Investigators mask treatment assignment measure IOP determine add medication .</detailed_description>
	<mesh_term>Glaucoma</mesh_term>
	<mesh_term>Cataract</mesh_term>
	<mesh_term>Glaucoma , Open-Angle</mesh_term>
	<criteria>previous diagnosis POAG IOP &gt; 18 mm Hg three separate visit one medication , subject least two medication uncontrolled IOP three separate visit . patient deem likely follow surgeon instruction able give inform consent . glaucoma diagnosis POAG presence peripheral anterior synechiae ( PAS ) cloudy cornea likely inhibit gonioscopic view angle previous ocular surgery history trauma ocular surface disease presence peripheral anterior synechiae ( PAS ) cloudy cornea likely inhibit gonioscopic view angle</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2009</verification_date>
	<keyword>POAG</keyword>
	<keyword>Combination glaucoma &amp; cataract procedure</keyword>
	<keyword>trabecular micro-bypass stent</keyword>
	<keyword>iStent</keyword>
</DOC>